The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Open accessAbstract
Dipeptide repeat peptides on the attack: Certain neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), are associated with expanded dipeptides translated from RNA transcripts of disease-associated genes (see the Perspective by West and Gitler). Kwon et al. show that the peptides encoded by the expanded repeats in the C9orf72 gene interfere with the way cells make RNA and kill cells. These effects may account for how this genetic form of ALS causes disease. Working in Drosophila , Mizielinska et al. aimed to distinguish between the effects of repeat-containing RNAs and the dipeptide repeat peptides that they encode. The findings provide evidence that dipeptide repeat proteins can cause toxicity directly. Science , this issue p. 1139 and p. 1192 ; see also p. 1118
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These carriers account for the largest amount of familial cases of FTD, in which abnormal GGGGCC expansions in the non‐coding region of the C9orf72 gene produce toxic RNA foci 41 , 42 and dipeptide repeat proteins (DPRs).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationThe C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210
Self-citationAsh, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
GAL4 system in drosophila: A fly geneticist's swiss army knife
Duffy, J. B. (2002) · genesis · doi:10.1002/gene.10150 · Cited by 1,099
Drozdzowska, B., Pluskiewicz, W., Halaba, Z. P., Misiołek, H., & Beck, B. R. (2005) · Cited by 984
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 928
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
A conditional tissue-specific transgene expression system using inducible GAL4
Osterwalder, T., Yoon, K. S., White, B. H., & Keshishian, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221303298 · Cited by 804
Cited by
Sorted by citations
Items 301–400 of 739
Latallo, M. J., Wang, S., Dong, D., Nelson, B., Livingston, N. M., Wu, R., Zhao, N., Stasevich, T. J., Bassik, M. C., Sun, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41339-x · Cited by 32
Vulnerability of microRNA biogenesis in FTD–ALS
Eitan, C., & Hornstein, E. (2016) · Brain Research · doi:10.1016/j.brainres.2015.12.063 · Cited by 38
Arginine-rich Peptides Can Actively Mediate Liquid-liquid Phase Separation
Boeynaems, S., Decker, M. D., Tompa, P., & Bosch, L. V. D. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2525 · Cited by 34
Trageser, K. J., Smith, C., Herman, F. J., Ono, K., & Pasinetti, G. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01298 · Cited by 31
West, R. J. H., Sharpe, J. L., Voelzmann, A., Munro, A. L., Hahn, I., Baines, R., & Pickering-Brown, S. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01028-y · Cited by 35
Self-citationBožič, J., Motaln, H., Pucer, A., Markič, L., Tripathi, P., Yamoah, A., Aronica, E., Lee, Y., Heilig, R., Fischer, R., et al. (2021) · Brain · doi:10.1093/brain/awab300 · Cited by 36
Anoar, S., Woodling, N. S., & Niccoli, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.786076 · Cited by 37
Self-citationMarlin, E., Viu-Idocin, C., Arrasate, M., & Aragón, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147823 · Cited by 32
Czuppa, M., Dhingra, A., Zhou, Q., Schludi, C., König, L. E., Scharf, E., Farny, D., Dalmia, A., Täger, J., Castillo-Lizardo, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110913 · Cited by 29
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
Laneve, P., Tollis, P., & Caffarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910285 · Cited by 32
A nascent peptide code for translational control of mRNA stability in human cells
Burke, P. C., Park, H., & Subramaniam, A. R. (2022) · Nature Communications · doi:10.1038/s41467-022-34664-0 · Cited by 31
Jafarinia, H., der Giessen, E. V., & Onck, P. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-25732-y · Cited by 32
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Tang, X., Toro, A., Sahana, T. G., Gao, J., Chalk, J. L., Oskarsson, B., & Zhang, K. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00383-7 · Cited by 34
Long non coding RNAs and ALS: Still much to do
Gagliardi, S., Pandini, C., Garofalo, M., Bordoni, M., Pansarasa, O., & Cereda, C. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.11.004 · Cited by 31
Licata, N. V., Cristofani, R., Salomonsson, S. E., Wilson, K. M., Kempthorne, L., Vaizoglu, D., D’Agostino, V., Pollini, D., Loffredo, R., Pancher, M., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105026 · Cited by 29
Self-citationGuo, W., Wang, H., Tharkeshwar, A. K., Couthouis, J., Braems, E., Masrori, P., Schoor, E. V., Fan, Y., Ahuja, K., Moisse, M., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12760 · Cited by 31
Kriachkov, V. A., Ormsby, A. R., Kusnadi, E. P., McWilliam, H. E. G., Mintern, J. D., Amarasinghe, S. L., Ritchie, M. E., Furic, L., & Hatters, D. M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102774 · Cited by 31
Translational control in brain pathologies: biological significance and therapeutic opportunities
Delaidelli, A., Jan, A., Herms, J. W., & Sorensen, P. H. B. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01971-8 · Cited by 31
Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients
Mordes, D. A., Prudencio, M., Goodman, L. D., Klim, J. R., Moccia, R., Limone, F., Pietiläinen, O. P. H., Chowdhary, K., Dickson, D. W., Rademakers, R., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0555-8 · Cited by 33
Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Ghasemi, M., Keyhanian, K., & Douthwright, C. L. (2021) · Cells · doi:10.3390/cells10020249 · Cited by 35
Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD
Solomon, D. A., Smikle, R., Reid, M. J., & Mizielinska, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.664151 · Cited by 33
Self-citationThe Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis
Vanneste, J., & Bosch, L. V. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212175 · Cited by 32
Fu, R., Tsai, C.-W., Chiu, S., Liu, S., Chiang, Y.-T., Kuo, Y.-H., Shyu, W., & Lin, S. (2022) · Cells · doi:10.3390/cells11193128 · Cited by 29
Park, J., Wu, Y., Shao, W., Gendron, T. F., van der Spek, S. J. F., Sultanakhmetov, G., Basu, A., Otero, P. C., Jones, C. J., Jansen‐West, K. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112822 · Cited by 30
Biological Spectrum of Amyotrophic Lateral Sclerosis PrionsPreprint
Polymenidou, M., & Cleveland, D. W. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024133 · Cited by 29
Emerging role of RNA•DNA hybrids inC9orf72-linked neurodegeneration
Wang, J., Haeusler, A. R., & Simko, E. A. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.995490 · Cited by 31
Herrmann, D., & Parlato, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2806-1 · Cited by 29
Pathological phase transitions in ALS-FTD impair dynamic RNA–protein granules
Nedelsky, N. B., & Taylor, J. P. (2021) · RNA · doi:10.1261/rna.079001.121 · Cited by 31
Status of ALS treatment, insights into therapeutic challenges and dilemmas
Khamaysa, M., & Pradat, P.-F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101601 · Cited by 28
Lin, G., Mao, D., & Bellen, H. J. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.004 · Cited by 29
Stopford, M. J., Higginbottom, A., Hautbergue, G. M., Cooper‐Knock, J., Mulcahy, P. J., Vos, K. J. D., Renton, A. E., Pliner, H. A., Calvo, A., Chiò, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx022 · Cited by 28
La accesibilidad de los portales web de las universidades públicas andaluzas
Balsells, L. A. C., González, J. C. G., Balsells, M. A. C., & Chamorro, V. A. P. (2017) · Revista española de Documentación Científica · doi:10.3989/redc.2017.2.1372 · Cited by 32
Cacciottolo, R., Ciantar, J., Lanfranco, M., Borg, R. M., Vassallo, N., Bordonné, R., & Cauchi, R. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-53508-4 · Cited by 28
Kempthorne, L., Vaizoglu, D., Cammack, A. J., Carcolé, M., Roberts, M. J., Mikheenko, A., Fisher, A., Suklai, P., Muralidharan, B., Kroll, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55550-x · Cited by 27
Self-citationHukema, R. K., Riemslagh, F. W., Melhem, S., van der Linde, H. C., Severijnen, L.-A. W. F. M., Edbauer, D., Maas, A., Charlet‐Berguerand, N., Willemsen, R., & Swieten, J. C. V. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0166-y · Cited by 27
RetractedAtilano, M. L., Grönke, S., Niccoli, T., Kempthorne, L., Hahn, O., Morón-Oset, J., Hendrich, O., Dyson, M. C., Adams, M. L., Hull, A. J., et al. (2021) · eLife · doi:10.7554/elife.58565 · Cited by 27
Self-citationNEAT1 lncRNA and amyotrophic lateral sclerosis
Nishimoto, Y., Nakagawa, S., & Okano, H. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105175 · Cited by 28
Hoem, G., Larsen, K. B., Øvervatn, A., Brech, A., Lamark, T., Sjøttem, E., & Johansen, T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00249 · Cited by 27
Boeynaems, S., Ma, X. R., Yeong, V., Ginell, G. M., Chen, J.-H., Blum, J. A., Nakayama, L., Sanyal, A., Briner, A., Haver, D. V., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.03.09.531820 · Cited by 24
Yeast screen for modifiers of C9orf72 poly(glycine-arginine) dipeptide repeat toxicity
Chai, N., & Gitler, A. D. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy024 · Cited by 25
Studying ALS: Current Approaches, Effect on Potential Treatment Strategy
Ustyantseva, E., Medvedev, S. P., & Zakian, S. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41283-8_11 · Cited by 26
Castelli, L. M., Huang, W.-P., Lin, Y.-H., Chang, K., & Hautbergue, G. M. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200690 · Cited by 27
Verdone, B. M., Cicardi, M. E., Wen, X., Sriramoji, S., Russell, K. A., Markandaiah, S. S., Jensen, B. K., Krishnamurthy, K., Haeusler, A. R., Pasinelli, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09593-z · Cited by 23
HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS
Braems, E., Bercier, V., Schoor, E. V., Heeren, K., Beckers, J., Fumagalli, L., Dedeene, L., Moisse, M., Geudens, I., Hersmus, N., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02471-y · Cited by 27
Berson, A., Goodman, L. D., Sartoris, A., Otte, C. G., Aykit, Y. J., Lee, V. M. ‐., Trojanowski, J. Q., & Bonini, N. M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0710-x · Cited by 25
de Calbiac, H., Renault, S., Haouy, G., Jung, V. A., Roger, K., Zhou, Q., Campanari, M., Chentout, L., Demy, D. L., Marian, A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2358736 · Cited by 23
Saha, S., & Hyman, A. A. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201706034 · Cited by 25
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Ramesh, N., Daley, E. L., Gleixner, A. M., Mann, J. R., Kour, S., Mawrie, D., Anderson, E. N., Kofler, J., Donnelly, C. J., Kiskinis, E., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01060-y · Cited by 25
Antisense, but not sense, repeat expanded RNAs activate PKR/eIF2α-dependent ISR in C9ORF72 FTD/ALS
Parameswaran, J., Zhang, N., Braems, E., Tilahun, K., Pant, D. C., Yin, K., Asress, S., Heeren, K., Banerjee, A., Davis, E., et al. (2023) · eLife · doi:10.7554/elife.85902 · Cited by 27
Ribosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats
Tseng, Y., Krans, A., Malik, I., Deng, X., Yildirim, E., Övünç, S. S., Tank, E. M. H., Jansen‐West, K. R., Kaufhold, R. T., Gómez, N., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae137 · Cited by 26
Au, W. H., Miller‐Fleming, L., Sánchez-Martínez, Á., Lee, J., Twyning, M. J., Prag, H. A., Raik, L., Allen, S. P., Shaw, P. J., Ferraiuolo, L., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402853 · Cited by 27
L3MBTL1 regulates ALS/FTD-associated proteotoxicity and quality control
Lu, J., Periz, G., Lu, Y., Tang, Q., Liu, Y., Zhang, T., Shah, Y., Thombre, R., Aljumaah, R., Li, W., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0384-5 · Cited by 24
The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS
Kawabe, Y., Mori, K., Yamashita, T., Gotoh, S., & Ikeda, M. (2020) · The EMBO Journal · doi:10.15252/embj.2019102700 · Cited by 25
Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins
Gao, J., Mewborne, Q. T., Girdhar, A., Sheth, U., Coyne, A. N., Punathil, R., Kang, B. G., Dasovich, M., Veire, A. M., Hernandez, M. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq3215 · Cited by 26
Dong, D., Zhang, Z., Li, Y., Latallo, M. J., Wang, S., Nelson, B., Wu, R., Krishnan, G., Gao, F., Wu, B., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adl1030 · Cited by 22
Mori, K., Gotoh, S., Yamashita, T., Uozumi, R., Kawabe, Y., Tagami, S., Kamp, F., Nuscher, B., Edbauer, D., Haass, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101120 · Cited by 23
Martín‐Guerrero, S. M., Markovinović, A., Mórotz, G. M., Salam, S., Noble, W. J., & Miller, C. C. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.915931 · Cited by 24
DNA-initiated epigenetic cascades driven by C9orf72 hexanucleotide repeat
Liu, Y., Huang, Z., Liu, H., Ji, Z., Arora, A., Cai, D., Wang, H., Liu, M., Simko, E. A. J., Zhang, Y., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.022 · Cited by 22
Santarelli, S., Londero, C., Soldano, A., Candelaresi, C., Todeschini, L., Vernizzi, L., & Bellosta, P. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1082047 · Cited by 25
Shin, J., Salameh, J. S., & Richter, J. D. (2016) · Scientific Reports · doi:10.1038/srep29395 · Cited by 23
Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease
Odeh, H. M., Fare, C. M., & Shorter, J. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167220 · Cited by 22
RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies
Guo, S., Nguyen, L., & Ranum, L. P. W. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.11.001 · Cited by 22
Genetic architecture of motor neuron diseases
Chaudhary, R., Agarwal, V., Rehman, M., Kaushik, A. S., & Mishra, V. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120099 · Cited by 24
Pathophysiology of ion channels in amyotrophic lateral sclerosis
Stringer, R. N., & Weiss, N. (2023) · Molecular Brain · doi:10.1186/s13041-023-01070-6 · Cited by 23
C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis
Lai, J. D., & Ichida, J. K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134523 · Cited by 25
Jiang, X., Schaeffer, L., Patni, D., Russo, T., Lee, C.-Z., Aguilar, C., Marques, C., Jansen‐West, K. R., Hruška-Plocháň, M., Ray-Soni, A., et al. (2026) · Science · doi:10.1126/science.adv2600 · Cited by 22
Frontotemporal Dementia and Glucose Metabolism
Garrett, L. R., & Niccoli, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.812222 · Cited by 20
Self-citationModeling neuromuscular diseases in zebrafish
Singh, J., & Patten, S. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1054573 · Cited by 21
How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD
Spijker, H. M. V. ‘., & Almeida, S. (2023) · Gene · doi:10.1016/j.gene.2023.147167 · Cited by 22
Sahana, T. G., Chase, K. J., Liu, F., Lloyd, T. E., Rossoll, W., & Zhang, K. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-22.2023 · Cited by 21
Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS
McGoldrick, P., & Robertson, J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1247297 · Cited by 22
Morón-Oset, J., Supèr, T., Eßer, J., Isaacs, A. M., Grönke, S., & Partridge, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0860-x · Cited by 20
Self-citationThe molecular pathogenesis of repeat expansion diseases
Fujino, Y., & Nagai, Y. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200143 · Cited by 20
Dubey, S. K., Maulding, K., Sung, H., & Lloyd, T. E. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111379 · Cited by 20
Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Ito, H., Sugiki, T., Murata, A., Ishiguro, A., Gendron, T. F., Mori, K., et al. (2023) · eLife · doi:10.7554/elife.84338 · Cited by 31
Bagyinszky, E., Hulme, J., & An, S. S. A. (2023) · Cells · doi:10.3390/cells12151948 · Cited by 21
C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?
Sellier, C., Corcia, P., Vourc’h, P., & Dupuis, L. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.03.008 · Cited by 24
Goodman, L. D., & Bonini, N. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101697 · Cited by 20
He, F., Flores, B. N., Krans, A., Frazer, M. A., Natla, S., Niraula, S., Adefioye, O., Barmada, S. J., & Todd, P. K. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01002-8 · Cited by 18
Chen, L., Shao, Q., Zhang, W., Yang, M., Chang, Q., Chen, R., & Chen, J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz230 · Cited by 20
Sun, S., Shen, Y., Zhang, X., Ding, N., Xu, Z., Zhang, Q., & Li, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.016 · Cited by 19
Furuta, N., Tsukagoshi, S., Hirayanagi, K., & Ikeda, Y. (2019) · Brain Research · doi:10.1016/j.brainres.2018.12.045 · Cited by 19
Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice
Pattamatta, A., Nguyen, L., Olafson, H. R., Scotti, M. M., Laboissonniere, L. A., Richardson, J. I., Berglund, J. A., Zu, T., Wang, E. T., & Ranum, L. P. W. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa279 · Cited by 22
RNA Is a Double-Edged Sword in ALS Pathogenesis
Zaepfel, B. L., & Rothstein, J. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.708181 · Cited by 20
A Fluorescence-Based Genetic Screen to Study Retinal Degeneration in Drosophila
Huang, Y., Xie, J., & Wang, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144925 · Cited by 19
p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
Usluer, S., Spreitzer, E., Bourgeois, B. M. R., & Madl, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111431 · Cited by 19
Jiménez-Villegas, J., Kirby, J., Mata, A., Cadenas, S., Turner, M. R., Malaspina, A., Shaw, P. J., Cuadrado, A., & Rojo, A. I. (2022) · Antioxidants · doi:10.3390/antiox11101897 · Cited by 21
C9orf72 polyPR directly binds to various nuclear transport components
Jafarinia, H., van der Giessen, E., & Onck, P. R. (2024) · eLife · doi:10.7554/elife.89694 · Cited by 18
Ishiura, H., & Tsuji, S. (2015) · Journal of Neurogenetics · doi:10.3109/01677063.2015.1085980 · Cited by 19
Drosophila models of amyotrophic lateral sclerosis with defects in RNA metabolism
Zhang, K., Coyne, A. N., & Lloyd, T. E. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.043 · Cited by 21
A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats
Corman, A., Jung, B., Häggblad, M., Bräutigam, L., Lafarga, V., Lidemalm, L., Hühn, D., Puigvert, J. C., & Fernández-Capetillo, Ó. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.10.020 · Cited by 19
A Peptidylic Inhibitor for Neutralizing (GGGGCC)-Associated Neurodegeneration in C9ALS-FTD
Zhang, Q., An, Y., Chen, Z. S., Koon, A. C., Lau, K., Ngo, J. C. K., & Chan, H. Y. E. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.015 · Cited by 18
Riemslagh, F. W., Lans, H., Seelaar, H., Severijnen, L.-A. W. F. M., Melhem, S., Vermeulen, W., Aronica, E., Pasterkamp, R. J., Swieten, J. C. V., & Willemsen, R. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0694-6 · Cited by 18
Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats
Dong, W., Zhang, L., Sun, C., Gao, X., Guan, F., Li, J., Chen, W., Ma, Y., & Zhang, L. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12129 · Cited by 18
Castro, A. F., Loureiro, J. R., Bessa, J., & Silveira, I. (2020) · Genes · doi:10.3390/genes11121418 · Cited by 18
Simple animal models for amyotrophic lateral sclerosis drug discovery
Patten, S. A., Parker, J. A., Wen, X., & Drapeau, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1196183 · Cited by 20
Wang, X., Hao, L., Saur, T., Joyal, K. G., Zhao, Y. Y., Zhai, D., Li, J., Pribadi, M., Coppola, G., Cohen, B. M., et al. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00113 · Cited by 20
C9orf72 poly-PR forms anisotropic condensates causative of nuclear TDP-43 pathology
Hodgson, R. E., Rayment, J. A., Huang, W.-P., Avila, A. S., Ellis, B. C. S., Lin, Y.-H., Soni, N., Hautbergue, G. M., & Shelkovnikova, T. A. (2024) · iScience · doi:10.1016/j.isci.2024.110937 · Cited by 17
Sponging of cellular proteins by viral RNAs
Charley, P. A., & Wilusz, J. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.09.001 · Cited by 17
Als and Ftd: Insights into the disease mechanisms and therapeutic targets
Liščić, R. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.012 · Cited by 17
Metadata
- Authors
- Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., Cleverley, K., Nicoll, A. J., Pickering-Brown, S., Dols, J., Cabecinha, M., Hendrich, O., Fratta, P., Fisher, E. M. C., Partridge, L., & Isaacs, A. M.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- Max Planck Institute for Biology of Ageing (DE)
- MRC Prion Unit (GB)
- University of Manchester (GB)
- University College London (GB)
- Corresponding author
- Mizielinska, Sarah
- Grönke, Sebastian
- Niccoli, Teresa
- Partridge, Linda
- Isaacs, Adrian M.
- ORCID
- Venue
- Science
- Published
- 2014-09-05
- Volume
- 345
- Issue
- 6201
- Pages
- 1192-1194
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4944841
- OpenAlex
- W2137039075
- Cited by
- 740
- References
- 37
- Citations by year
- 2026: 30 · 2025: 44 · 2024: 49 · 2023: 70 · 2022: 57 · 2021: 90 · 2020: 69 · 2019: 62 · 2018: 62 · 2017: 62 · 2016: 68 · 2015: 59 · 2014: 18
- FWCI
- 45.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Wellcome Trust (098565, 089701, 081394)
- Brain Research UK (13173)
- National Institute for Health and Care Research (ACF-2012-18-009)
- Motor Neurone Disease Association (ISAACS/APR13/818-791)
- Institute on the Environment, University of Minnesota
- Medical Research Council (MR/K018523/1, MR/J004022/1, MR/L021056/1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- C9orf72, GGGGCC repeat expansion, dipeptide repeat proteins, repeat-associated non-ATG translation, frontotemporal dementia, amyotrophic lateral sclerosis, neurodegeneration, arginine-rich proteins, Drosophila model
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Animals, Dipeptides, Disease Models, Animal, Drosophila melanogaster, Escherichia coli, Humans, Neurons, Proteins, DNA Repeat Expansion, Cell Line, Tumor, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review